John Temperato - 27 Mar 2023 Form 4 Insider Report for 9 METERS BIOPHARMA, INC. (NMTR)

Role: Chief Executive Officer, Director
Signature: /s/ Bethany Sensenig, as power of attorney
Issuer symbol: NMTR
Transactions as of: 27 Mar 2023
Transactions value $: $0
Form type: 4
Filing time: 29 Mar 2023, 16:01:18 UTC
Previous filing: 08 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NMTR	Common Stock	Award		+68,815	+96.41%		140,192	27 Mar 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units ("RSUs") granted pursuant to the 9 Meters Biopharma, Inc. 2022 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting date. The RSUs vest as follows: 34,408 shares vest on April 15, 2023 and 34,407 shares vest on December 31, 2023. The vesting of the December 31, 2023 RSUs will accelerate upon a change in control prior to December 31, 2023.

Content

Represents Restricted Stock Units ("RSUs") granted pursuant to the 9 Meters Biopharma, Inc. 2022 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting date. The RSUs vest as follows: 34,408 shares vest on April 15, 2023 and 34,407 shares vest on December 31, 2023. The vesting of the December 31, 2023 RSUs will accelerate upon a change in control prior to December 31, 2023.